Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine.

[1]  Ralph Mazitschek,et al.  Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases. , 2004, Current opinion in chemical biology.

[2]  Y. Gho,et al.  Capsaicin Inhibits in Vitro and in Vivo Angiogenesis , 2004, Cancer Research.

[3]  J. Foidart,et al.  Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1‐MMP, MMP‐2 and MMP‐9 in human glioblastomas , 2003, International journal of cancer.

[4]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[5]  K. Nose,et al.  HIF-1-dependent VEGF reporter gene assay by a stable transformant of CHO cells. , 2003, Biological & pharmaceutical bulletin.

[6]  S. Natori,et al.  Involvement of H2O2 and O2‐ in the cytotoxicity of N‐β‐alanyl‐5‐S‐glutathionyl‐3,4‐dihydroxyphenylalanine (5‐S‐GAD), a novel insect‐derived anti‐tumor compound , 2003, Cancer science.

[7]  A. Bikfalvi,et al.  Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. , 2002, Trends in pharmacological sciences.

[8]  M. Shibuya,et al.  Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling. , 2002, Molecular cancer therapeutics.

[9]  K. Wierzba,et al.  A Potential Use of a Synthetic Retinoid TAC‐101 as an Orally Active Agent That Blocks Angiogenesis in Liver Metastases of Human Stomach Cancer Cells , 2001, Japanese journal of cancer research : Gann.

[10]  M. Pepper.  Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[11]  Y. Shibutani,et al.  Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis. , 1999, European journal of pharmacology.

[12]  M. Noda,et al.  Induction of apoptosis of monocyte‐macrophage lineage cells by 5‐S‐GAD , 1999, FEBS letters.

[13]  Y. Uehara,et al.  Inhibitory effects of 5-S-GAD on phosphorylation of V-SRC and BCR-ABL tyrosine kinase. , 1998, Biological & pharmaceutical bulletin.

[14]  S. Itohara,et al.  Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. , 1998, Cancer research.

[15]  M. Shibuya,et al.  The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma. , 1997, Biochemical and biophysical research communications.

[16]  Y. Uehara,et al.  Inhibition of protein tyrosine kinase by 5-S-GAD, a novel antibacterial substance from an insect. , 1997, Biochemical and biophysical research communications.

[17]  T. Takeuchi,et al.  Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo. , 1997, Anticancer research.

[18]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[19]  I. Shimada,et al.  Purification and Characterization of N-β-Alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine, a Novel Antibacterial Substance of Sarcophaga peregrina (Flesh Fly)* , 1996, The Journal of Biological Chemistry.

[20]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[21]  T. Oikawa.  Strategies to Find Novel Angiogenesis Inhibitors as Potential Therapeutic Agents for Cancer , 1995, Current Medicinal Chemistry.

[22]  T. Tsuruo,et al.  Anti-tumor effect of N-beta-alanyl-5-S-glutathionyldihydroxyphenylalanine (5-S-GAD), a novel anti-bacterial substance from an insect. , 2000, Anticancer research.

[23]  J. Cherrington,et al.  New paradigms for the treatment of cancer: the role of anti-angiogenesis agents. , 2000, Advances in cancer research.